MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0069648
Pesino Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹29.51 Cr
▲ 50% YoY
Net profit · FY 2024
₹95.56 Lakh
Net margin 3.2%
EBITDA · FY 2024
₹99.66 Lakh
EBITDA margin 3.4%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹1.5 Cr
Secured borrowings
Company age
23 yrs
Est. 2003
Directors on board
3
As per MCA filings
About Pesino Pharmaceuticals Private Limited
Data last updated:
Pesino Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 June 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC140865. Its GSTIN is 27AADCP0334N1ZC (Maharashtra).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Shilpa Agnelo Almeida and Agnelo Anselmo Almeida.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 11/B 405 Ashish Complexc S C Road No 4 Dahisar East, Mumbai, Maharashtra, India – 400068.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.51 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹95.56 Lakh (net margin 3.2%) and EBITDA of ₹99.66 Lakh (EBITDA margin 3.4%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹1.5 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Pesino Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0069648). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pesinopharma.com.
Company details
CIN U24230MH2003PTC140865
Registration Number 140865
Incorporation Date 12 June 2003
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0069648
Key People
Shilpa Agnelo Almeida Director Agnelo Anselmo Almeida Director Shawn Almeida Agnelo Director Recognitions & Rankings of Pesino Pharmaceuticals
Contact details
Pesino Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is pesinopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address11/B 405 Ashish Complexc S C Road No 4 Dahisar East, Mumbai, Maharashtra, India – 400068
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pesino Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Pesino Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Pesino Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Pesino Pharmaceuticals Private Limited, buy the company report.
Financials of Pesino Pharmaceuticals Private Limited
FY 2024 filings availablePesino Pharmaceuticals Private Limited reported revenue of ₹29.51 Cr (up 50% YoY) for FY 2024.
Revenue · FY 2024
₹29.51 Cr ▲ 50%
Net profit · FY 2024
₹95.56 Lakh margin 3.2%
EBITDA · FY 2024
₹99.66 Lakh margin 3.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 50%
3 years · compounded
▲ 2%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 62%
3 years · compounded
▲ 17%
5 years · compounded
▼ 1%
Revenue rose 50% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹99.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹95.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pesino Pharmaceuticals Private Limited, buy the company report.
Board of directors of Pesino Pharmaceuticals Private Limited
Pesino Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shilpa Agnelo Almeida | Director | 12 Jun 2003 | 23 Years 4 Months | Current |
| Agnelo Anselmo Almeida | Director | 12 Jun 2003 | 23 Years 4 Months | Current |
| Shawn Almeida Agnelo | Director | 01 Apr 2019 | 7 Years 7 Months | Current |
Peer comparison
Pesino Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cedric Pharmaceuticals Private Limited | ₹29.69 Cr (FY 2025) | 15.0% | Delhi, India | |||
| Namrata Agencies Private Limited | ₹29.67 Cr (FY 2025) | -36.0% | Thane, Maharashtra, India | |||
| Ventis Pharmaceuticals Private Limited | ₹29.55 Cr (FY 2025) | 32.0% | Ghaziabad, Uttar Pradesh, India | |||
| Pesino Pharmaceuticals Private Limitedthis company | ₹29.51 Cr (FY 2024) | ₹95.56 Lakh | 3.2% | 50.0% | Mumbai, Maharashtra, India | |
| Le-Mantus Pharmaceuticals Private Limited | ₹29.31 Cr (FY 2024) | -27.0% | Delhi, India |
To see the full peer comparison of Pesino Pharmaceuticals Private Limited, buy the company report.
Auditor
Pesino Pharmaceuticals Private Limited is audited by P.G. KANVINDE & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.G. KANVINDE & ASSOCIATES | FY 2022 | 101232 |
Shareholding
The shareholding of Pesino Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pesino Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Aug 2007 | 10068693 | Others | ₹1.5 Cr | Open |
To see the full charge records of Pesino Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Pesino Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, MORBI, Gujarat | Criminal complaint | Filed against the company by an individual | Disposed |
To see the full case history of Pesino Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pesino Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pesino Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCP0334N1ZC | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pesino Pharmaceuticals Private Limited, buy the company report.
Recent activity
Pesino Pharmaceuticals Private Limited has 4 board changes on record since 2003: 3 appointments and 1 cessation. The latest: Shawn Almeida Agnelo ceased to be Additional Director on 30 Sep 2019.
AGM
Pesino Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Pesino Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I.
Ceased
Shawn Almeida Agnelo ceased to be Additional Director.
Charges
A charge with Others of Rs. 1.50 Cr registered on 11 Aug 2007 with Charge ID 10068693 was modified on 03 Aug 2019.
Appointed
Shawn Almeida Agnelo was appointed as Director.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 10068693 was registered on 11 Aug 2007.
Appointed
Agnelo Anselmo Almeida was appointed as Director.
Appointed
Shilpa Agnelo Almeida was appointed as Director.
Incorporation
12 Jun 2003
Pesino Pharmaceuticals Private Limited was registered on 12 Jun 2003 with Roc Mumbai I & aged 23 years 4 months as per MCA records.
Frequently asked questions
Pesino Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 June 2003 (23+ years old) and is registered under CIN U24230MH2003PTC140865.
Pesino Pharmaceuticals has 3 current directors:
- Shilpa Agnelo Almeida - Director
- Agnelo Anselmo Almeida - Director
- Shawn Almeida Agnelo - Director
The latest financial statements of Pesino Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Pesino Pharmaceuticals is 27AADCP0334N1ZC, registered in Maharashtra.
The CIN (Corporate Identification Number) of Pesino Pharmaceuticals is U24230MH2003PTC140865. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pesino Pharmaceuticals has 1 court case on record: 1 filed against it.
Pesino Pharmaceuticals was incorporated on 12 June 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Pesino Pharmaceuticals by revenue are Cedric Pharmaceuticals Private Limited, Namrata Agencies Private Limited, Ventis Pharmaceuticals Private Limited, Le-Mantus Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Shawn Almeida Agnelo ceased to be Additional Director on 30 Sep 2019. Shawn Almeida Agnelo was appointed as Director on 01 Apr 2019. Agnelo Anselmo Almeida was appointed as Director on 12 Jun 2003. Pesino Pharmaceuticals has 4 board changes on record in total.
Yes, Pesino Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-MH-19-0069648).
Pesino Pharmaceuticals can be reached through the website pesinopharma.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages